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Endovascular repair of ruptured abdominal aortic
aneurysm does not confer survival benefits over
open repair
Naveed Saqib, MD,a Sun Cheol Park, MD,a Taeyoung Park, PhD,b Robert Y. Rhee, MD,a
Rabih A. Chaer, MD,aMichel S.Makaroun,MD,a and Jae-Sung Cho,MD,a Pittsburgh, Pa; and Seoul, Korea
Objective: Endovascular repair of ruptured abdominal aortic aneurysm (rAAA) is being increasingly performed despite
lack of good evidence for its superiority. Other reported studies suffer from patient selection and publication bias with
limited follow-up. This study is a single-center propensity score comparing early and midterm outcomes between open
surgical repair (OSR) and endovascular repair of rAAA (REVAR).
Methods: A retrospective review from January 2001 to November 2010 identified 312 patients who underwent rAAA
repairs. Thirty-one patients with antecedent AAA repair and three with incomplete records were excluded, leaving 37
REVARs and 241 OSRs. Propensity score-based matching for sex, age, preoperative hemodynamic status, surgeon’s
annual AAA volume, and preoperative cardiopulmonary resuscitation was performed in a 1:3 ratio to compare outcomes.
Thirty-seven REVARs were matched with 111 OSRs. Late survival was estimated by Kaplan-Meier methods.
Results: Operative time and blood replacement were higher with OSR. Overall complication rates were similar (54%
REVAR vs 66% OSR; P  .23), except for higher incidences of tracheostomies (21% vs 3%; P  .015), myocardial
infarction (38% vs 18%; P .036), and acute tubular necrosis (47% vs 21%; P .009) withOSR.Operative mortality rates
were similar (22% REVAR vs 32% OSR), with an odds ratio of 0.63 for REVAR (95% confidence interval [0.24, 1.48];
P  .40). No differences in the incidences for secondary interventions for aneurysm- or graft-related complications were
noted (22% REVAR vs 22% OSR; P  .99). Kaplan-Meier estimates of 1-, 2-, and 3-year survival rates were also similar
(50%, 50%, 42% REVAR vs 54%, 52%, 47% OSR; P  .66).
Conclusions: REVAR for rAAA does not seem to conclusively confer either acute or late survival advantages. Routine use
of REVAR should be deferred until prospective, randomized trial data become available. ( J Vasc Surg 2012;56:614-20.)
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bWhile the majority of ruptured abdominal aortic aneu-
rysms (rAAAs) are repaired by open surgical method
(OSR), endovascular aneurysm repair of rAAA (REVAR) is
being increasingly used to treat rAAA. This enthusiasm
for REVAR was primarily borne from excellent results
reported in case reports and single-center series that have
adopted a standardized protocol for REVAR,1-7 meta-
analyses,8-10 and population-based studies.11-15 However,
these reports invariably suffer frompatient selection biaswith
uncontrolled confounding factors and limited follow-up.16-18
In addition, the selection of patients is poorly reported in
cohort studies, and some studies fail to discriminate urgent/
symptomatic from ruptured aneurysms. Also, poor results are
rarely published in the literature. Undoubtedly, these factors
may contribute to superior results observedwithREVARover
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614SR. Despite these limitations and the lack of good evidence
or its superiority, REVAR has been espoused as the preferen-
ial mode of therapy, such that even the utility of a prospective
andomized trial is debated.16,19
The aim of this study is to evaluate whether REVAR
onfers early and midterm survival benefits compared with
SR using propensity score matching for confounding
ariables.
ETHODS
Patient population. A retrospective review of all pa-
ients with ruptured infrarenal abdominal aortic aneurysm
rAAA) treated with REVAR or OSR between January 2001
nd November 2011 at the University of Pittsburgh Medical
enter (UPMC) was performed using a prospectively main-
ained database. Ruptured abdominal aortic aneurysm was de-
nedaseitherpresenceof freeperitonealbloodor retroperitoneal
ematoma on laparotomy, or presence of blood outside the
ortic wall on computed tomography scan.
Three hundred twelve patients were treated for rAAA
uring the study period. Patients with antecedent abdom-
nal aortic aneurysm (AAA) repairs (four previous open
epairs and 27 previous endovascular repairs) and three
atients with incomplete medical records were excluded
rom the study. Symptomatic patients without rupture
ere also excluded. The remaining 288 patients form the
asis for this study; 37 patients underwent EVAR and 251
atients received OSR.
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graphic data, comorbidities, physiologic data at presenta-
tion, time of presentation, time interval between presenta-
tion and treatment, operative data, and postoperative data
were collected from medical records for all patients.
Case selection. TheUPMC is a regional tertiary referral
hospital with high volume of open and emergent aortic sur-
gery cases. Selection of treatment in each case was made by the
vascular surgeon based on aortic morphology, time of presenta-
tion, hemodynamic stability, and the surgeon’s own experience.
Propensity score-based matching. To reduce the
confounding effects of covariate imbalance between OSR
and REVAR and selection bias, propensity score-based
matching was performed. The variables used for matching
included sex, gender, surgeon, hemodynamic stability, and
preoperative cardiopulmonary resuscitation. Patients who
underwent REVAR were matched to patients who under-
went OSR in a 1:3 ratio due to relative sample sizes of
REVAR and OSR patients and their distributions of pro-
pensity scores. Hence, 37 patients with REVAR were
matched with 111 patients with OSR, and their outcomes
were analyzed.
Outcomes. All intraoperative, in-hospital and30-daymor-
tality, postoperative morbidity, length of stay, and transfusion of
blood products were recorded. The Social Security Death Index
was used to evaluate the long-termmortality.
Statistical analysis. Kaplan-Meier analysis was used to
estimate the late survival rates of both patient groups.
Table I. Baseline characteristics of patients undergoing re
Variable REVAR (n
Patient demographics
Age (years) 74.9  8.2
Male 70.3 (26/
History of COPD 27.1 (10/
History of CVA 37.8 (14/
History of CAD 56.7 (21/
History of diabetes mellitus 40.5 (15/
History of PVD 37.8 (14/
History of hypertension 81.8 (30/
History of CRF 8.0 (3/
History of hemodialysis 3.0 (1/
Current smokers 43.2 (16/
Preoperative characteristics
Preoperative SBP 80 mm Hg 24.3 (9/
Preoperative CPR 8.1 (3/
ER to OR time (minutes) 94  21
Time of presentation
3 AM - 6 AM 22% (8/
6 AM - 1 PM 38% (14/
3 PM - 5 PM 22% (8/
8 PM - midnight 19% (7/
Blood work
Mean hemoglobin 11.3  2.3
Mean platelet count 213  40
Mean creatinine 1.3  0.8
CAD, Coronary artery disease; COPD, chronic obstructive pulmonary d
cerebrovascular accident; ER, emergency room;OR, operating room;OSR,O
aortic aneurysm; REVAR, endovascular repair of rAAA; SBP, systolic bloodTreatment selection bias was controlled by using propen- tity score-based matching for sex, age, preoperative hemo-
ynamic status, and surgeon’s annual AAA volume. All
aseline variables were included in logistic regression
odel to predict the probability that patient would receive
EVAR vs OSR upon presentation with rAAA. The fit of
he propensity score model to the data was assessed using
oncordance index.
ESULTS
The demographic data, comorbidities, and preoperative
haracteristics in each treatment group are illustrated in Table
. There were 26 males out of 37 patients (70.3%) treated with
EVAR and 69 males (62.2%) in 111 patients who underwent
SR (P .48). Themean age was 74.9 years in REVARgroup
nd 75.6 years in OSR group (P .76).
Patients presenting with hemodynamic instability, de-
ned as systolic blood pressure 80 mm Hg, were more
ikely to undergoOSR (P .03). Forty-nine patients (44%)
ho underwent OSR were hemodynamically unstable on
resentation, compared with only 24% of patients who
nderwent REVAR (nine patients). This difference results
rom the fact that the propensity score-based matching
alances the probability of being treated with REVAR as a
unction of multiple covariates, not each covariate directly.
n addition, due to the small sample size, it was not feasible
o find exact matching between the groups. The delay from
resentation until treatment was not statistically significant,
ut there was a trend toward delay in the REVAR group;
f ruptured abdominal aortic aneurysm
) OSR (n  111) P value
75.6  8.4 .76
62.2 (69/111) .48
31.1 (35/111) .53
36.8 (41/111) .85
63.7 (70/111) .42
33.2 (37/111) .65
21.6 (24/111) .50
86.7(96/111) .77
14.7 (16/111) .20
3.6 (4/111) .80
46.4 (41/111) .66
44.1 (49/111) .03
11.7 (13/111) .35
76  212 .09
.1
16% (18/111)
24% (27/111)
20% (22/111)
40% (44/111)
) 10.8  2.1 (99) .50
207  38 (99) .50
) 1.7  1.0 (95) .06
CPR, cardiopulmonary resuscitation; CRF, chronic renal failure; CVA,
urgical repair; PVD, peripheral vascular disease; rAAA, ruptured abdominal
ure.pair o
 37
37)
37)
37)
37)
37)
37)
37)
37)
37)
37)
37)
37)
8
37)
37)
37)
37)
(37
(37)
(37
isease;he time of presentation did not differ, either.
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September 2012616 Saqib et alIntraoperative variables are detailed in Table II. The
operative time was significantly longer in the OSR group
with higher fluid and blood product transfusion require-
ments. The length of stay in the intensive care unit and
hospital stay were lower following REVAR, but these were
not statistically significant (P  .13). The REVAR group
had a 7.3-day mean and 4.5-day median length of stay,
compared with a 23-day mean and 10.4-day median length
of stay in the OSR group.
The operative mortality rates, defined as intra-operative,
in-hospital, and 30-day mortality, were not statistically
different between the two groups (21.6% REVAR vs 31.5%
OSR; P  .34). To account for the differences in the
proportion of patients with hemodynamic instability (HI),
a logistic regression analysis was performed with and with-
out adjusting for HI. The difference in mortality between
REVAR and OSR adjusting for HI was not significant (P
.51 with the estimated difference in log odds of mortality
being .31). Overall complication rates were similar in
both groups (54% REVAR vs 66% OSR; P  .23) (Table
III). However, pulmonary failure requiring tracheostomy,
myocardial infarction, and acute tubular necrosis occurred
more frequently after OSR. The incidences of abdominal
compartment syndrome and bleeding requiring return to
the operating room did not differ.
At a mean of 3-year follow-up, the aneurysm-, graft-, or
Table II. Intraoperative variables
Variable REVAR OSR P value
OR time 138 198 .0001
Intraoperative fluid (mL) 2183 3594 .0007
Intraoperative colloids (mL) 566 1290 .02
Intraoperative pRBC (units) 3.06 6.86 .02
Intraoperative FFP (6 packs) 0.625 3.89 .0001
FFP, Fresh frozen plasma; OR, operating room; OSR, open surgical repair;
pRBC, packed red blood cells; rAAA, ruptured abdominal aortic aneurysm;
REVAR, endovascular repair of rAAA.
Table III. Comparison of morbidity and mortality after
REVAR and OSR
REVAR OSR P value
Mortality 21.6 (8/37) 31.5 (35/111) .35
Morbidity 54 (20/37) 66 (73/111) .23
LOS (days) 7.4  23.2  .13
MI 17.6 (7/37) 37.7 (42/111) .03
ARI 21 (8/37) 47 (52/111) .008
Hemodialysis 5.9 (2/37) 24.5 (27/111) .02
Pneumonia 8.8 (3/37) 24.5 (27/111) .05
Tracheostomy 2.9 (1/37) 20.8 (23/111) .015
ACS 11.4 (4/37) 11.3 (12/111) 1
Bowel resection 8.6 (3/37) 10.4 (11/111) 1
Postop hemorrhage 5.7 (2/37) 10.4 (11/111) .51
ACS, Abdominal compartment syndrome; ARI, acute renal injury; LOS,
length of stay;MI,myocardial infarction; OSR, open surgical repair; rAAA,
ruptured abdominal aortic aneurysm;REVAR, endovascular repair of rAAA.procedure-related secondary interventions were similar in toth groups: nine patients (25%) after REVAR vs 26 pa-
ients (23.4%) following OSR (P  .99) (Table IV).
aplan-Meier analysis (Fig) revealed no differences in late
urvival at 1, 2, and 3 years (P  .66). The probability of
urvival after REVAR was 50%, 50%, and 42%, respectively.
he corresponding figures for OSR were 54%, 52%,
nd 47%, respectively. Following OSR, aneurysm-
elated deaths occurred in 35 of 55 deaths in the first year;
4 deaths in year 2 and year 3 each were nonaneurysm-
elated deaths. Following REVAR, there were nine out of 12
neurysm-related deaths in the first year, three deaths not related
o aneurysm in the second post-REVAR year, and four deaths
ot related to aneurysm during the third post-REVAR year.
ISCUSSION
The perceived benefits of REVAR and improved results
rom selected studies1-5 have led some investigators to
romote an “endovascular-first” approach in the treatment
f rAAA2,20 since the first report of successful REVAR by
usuf et al in 1994.21 In fact, the utilization of REVAR has
teadily increased in the United States; the frequency of
EVAR increased over the 6-year study period from 5.9%
n 2001 to 18.9% in 200612; a similar trend was also
bserved in the present study. Such a trend was accompa-
ied by a decrease in mortality rates from 43% to 29% in a
eview of a Medicare database.22
The literature is replete with varying results after
EVAR.17 Some publications have shown no difference in
arly outcomes between REVAR and OSR,3,23,24 while
ome have shown superior results with REVAR. While
hese improved results can be found in propensity score-
atched13 or large population-based studies,11,12 the most
alient finding in review of the literature is that centers with
n instituted protocol are likely to have superior outcomes
ith REVAR.2,4,5,7 In a recent review of collected world
xperience with REVAR, the 30-day mortality was 21.2%
ith REVAR compared with 36.3% with OSR; in a sub-
roup analysis of 13 centers with standardized protocols
ith preferential REVAR the rate was 19.7%.5 Not all
enters with protocols are successful, however. A recent
nternational multicenter study with preferential REVAR
ailed to show early survival benefit even with heavy selec-
ion bias toward OSR for patients with cardiovascular in-
tability.24
A recent survey of the National Surgical Quality Im-
rovement Program (NSQIP) database showed no statisti-
ally significant reduction in mortality rate with REVAR.25
he same findings were noted in the current study. While the
ack of differences in the current study may be due to the
ow mortality rate with OSR for rAAA observed in our
nstitution26 and type II errors due to the small sample size,
he results resonate the conclusion of a large population-
ased study and propensity score-matched studies that
tated “institutional and surgeon experience were essential
o fully benefit from the use of this procedure for the
reatment of rAAA” and advocated for regionalization of
are to high-volume centers.11-13 It should also be noted
hat administrative databases are limited by their inability to
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geon’s experience and preference, suitability for REVAR,
referral pattern, and delay between presentation and treat-
ment. It is likely that the OSR mortality rates reported in
the literature are adversely affected by unfavorable hemo-
dynamic and anatomic characteristics, a phenomenon that
has been well documented. That there was a significantly
higher proportion of patients with hemodynamic instability
in the OSR group may explain, at least in part, the higher
(although statistical significance was not reached) mortality
rate following OSR observed in the current study. Had the
current study been matched for hemodynamic stability, the
mortality rate with OSR would be lower and the gap nar-
rower; the estimated difference in mortality rates after adjust-
Table IV. Early and late secondary interventions after RE
Complications
Post-OSR in
(n  26
Procedure-related
Re-exploration for ACS/hemorrhagea 12/26
Herniorrhaphy 4/26
Colectomy for ischemia 8/26
Lysis of adhesion 3/26
Cholecysectomy 1/26
Small bowel resection 3/26
Groin hematoma N/
Graft-related
Thrombosis 2/26
Graft infection 2/26
Endoleak N/
Vascular-related
Iliac PTA/stenting 1/26
Total 26/111
ACS, Abdominal compartment syndrome; OSR, open surgical repair; PT
aneurysm; REVAR, endovascular repair of rAAA.
Some patients may have more than one reintervention.
aIncludes splenectomy.
Fig. Kaplan-Meier curves of survival rates after endovas
(REVAR) and open surgical repair (OSR) of rAAAs.ing for hemodynamic instability became even smaller. tMultiple meta-analyses, systematic reviews, and population-
ased studies have shown survival advantages with REVAR.
owever, all these studies are flawed with heavy patient selec-
ion and publication biases, poorly controlled confounding
actors, and the lack of standardized reporting.27 Recog-
izing these limitations, the conclusions of these studies
tate that there is insufficient evidence to recommend wide-
pread adoption of REVAR and acknowledge the need for
large prospective, multicenter randomized trial,9 in light
f the fact that two earlier prospective randomized trials
the Nottingham and the Amsterdam Acute Aneurysm
AJAX] trials) have failed to show survival benefits with
EVAR.27-29 However, some refute the validity of such a
and OSR
ntions
ts)
Post-REVAR interventions
(n  9 patients) P
) 4/9 (44%)
) N/A
) 3/9 (33%)
) N/A
) 0
) 0
2/9 (22%)
) 4/9 (44%)
) 0
3/9 (33%)
) 1/9 (11%)
) 9/37 (25%) .99
rcutaneous transluminal angioplasty; rAAA, ruptured abdominal aortic
repair of ruptured abdominal aortic aneurysm (rAAA)VAR
terve
patien
(46%
(15%
(31%
(12%
(4%
(12%
A
(7%
(7%
A
(4%
(23%
A, pecularrial.16
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September 2012618 Saqib et alThere have been four prospective, randomized trials
that have either been conducted or are currently underway.
The Nottingham trial failed to show any reduction in
mortality with REVAR and was terminated due to poor
recruitment.17 The AJAX and the Endovasculaire vs
Chirurgie dans les Anévrysmes Rompus (ECAR) trials have
been designed to recruit hemodynamically stable REVAR-
suitable patients. These trials, while avoiding the ethical
dilemmas of randomizing hemodynamically unstable pa-
tients, will not be able to assess the role of an endovascular-
first strategy vs open repair on an intention-to-treat basis
since randomization occurs only after EVAR eligibility is
determined by a computed tomography scan. The AJAX
trial also failed to demonstrate any survival benefits with
REVAR and has been extended to recruit 120 patients,
increased from its original 80-patient recruitment goal.27
The Immediate Management of the Patient with Rupture:
Open Versus Endovascular repair (IMPROVE) trial is a
large trial, planned to recruit 600 patients, that randomizes
patients at the time of clinical diagnosis of rAAA regardless
of cardiovascular stability and before REVAR eligibility is
determined. As such, it will address the question of whether
or not the endovascular-first strategy provides survival ben-
efits over OSR.30 It is powered to show a difference of a
14% 30-day mortality rate and will identify factors that are
predictive of survival benefits.27,30
Widespread adoption of the endovascular-first ap-
proach for the treatment of rAAA at first glance is attractive.
It is minimally invasive and associated with lower compli-
cation rates, as shown in the current study. However,
implementation of such a protocol involves massive sys-
temic changes, such as stocking of endovascular stent grafts
and auxiliaries and around-the-clock availability of skilled
endovascular, radiologic, and nursing teams. It is not prag-
matic to undertake such systemic and systematic changes in
the absence of clear evidence of REVAR’s superiority. As
such, an institutional protocol for REVAR has not been
established at our institutions; given the size of the UPMC
system, this would represent a monumental task in a variety
of ways.
Furthermore, REVAR is not generalizable at present.
At best, about 50% of patients with rAAA may be treated
with REVAR.25 Cardiovascular stability plays a major role
in selection bias and outcome. Mehta et al31 revealed that
the mortality rate following REVAR for hemodynamically
unstable patients was 41%, similar to their open repair
mortality rate of 40%.32 They also noted thatmortality rates
after REVAR for women (33%) and octogenarians (38%)
were significantly higher than those for men (17%) and
those 80 years of age (15%). Furthermore, REVAR can
cause an increased risk of complications such as abdominal
compartment syndrome, which has been shown to be a
harbinger of poor outcome with mortality in excess of
60%.31,33,34 A recent study also showed an increased risk of
spinal cord ischemia with occlusion (temporary or perma-
nent) of the hypogastric artery.35 The benefit of REVAR
was not observed all across the hospitals. While a reduc-
tion in mortality was observed in teaching hospitals with OEVAR, a higher risk of in-hospital death was noted in
ommunity facilities.22,24 Identification of patient charac-
eristics, aneurysmmorphology, and intraoperative maneu-
ers that may influence the outcomes of REVAR is para-
ount.
In regard to midterm survival rates, the early survival
enefit does not seem to provide lasting effects. Survival
robabilities up to 3 years were similar between the two
roups in the present study. This is consistent with the
ndings of earlier reports.24,36,37 It has been well estab-
ished that a sustained risk of mortality exists even after
uccessful open repair of ruptured abdominal and thoraco-
bdominal aortic aneurysm,26,38,39 and patients appear to
e susceptible to it after REVAR.
There is still equipoise on what the best treatment for
AAA is. The data are conflicting, and many studies show-
ng improved outcomes with REVAR employed it preferen-
ially for patients with favorable anatomy and hemodynamic
tability.18,37 Preferential REVAR should be deferred until
esults of prospective, randomized trials are available and
redictive factors for its success are identified. Some pa-
ients may be harmed by indiscriminate insistence on
EVAR.
There are some limitations to this study inherent to its
etrospective nature with relatively small sample size. De-
pite propensity score-based matching to reduce selection
ias, due to the small number of patients, complete match-
ng was not feasible. As such, there may be a selection bias
n the choice of treatment rendered. The propensity score-
ased matching can only remove overt bias, but unlike
andomization, it cannot be expected to remove hidden
iases. Additionally, the propensity score-based method is
ased on the hypothesis that it balances only for the cova-
iates that were used to construct the score. Including
rrelevant covariates in propensity score-based matching
odel may reduce efficiency.
ONCLUSIONS
Endovascular repair for rAAA does not seem to conclu-
ively confer either acute or late survival advantages over
pen repair. Wide adoption and routine use of REVAR
hould be deferred until there is good evidence for its
uperiority.
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